The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.
Showing results 1 - 9 of 9
Prevalence of HIV PrEP Prescribing Among Persons With Commercial Insurance and Likely Injection Drug Use
This article from the Journal of the American Medical Association (JAMA) estimates HIV PrEP uptake among commercially insured persons with opioid or stimulant use disorder by injection drug use status in the USA.
Research, Service Delivery
Using Nominal Group Technique to Identify Barriers and Facilitators to Preventing HIV Using Combination Same-day Pre-exposure Prophylaxis and Medications for Opioid Use Disorder
This article from Harm Reduction Journal identifies barriers and facilitators to integrating PrEP services with provision of medications for opioid use disorder for people who use drugs in New Haven, Connecticut, USA.
Willingness to Pay for HIV Prevention Commodities Among Key Population Groups in Nigeria
This article from Global Health: Science and Practice investigates the willingness of gay and bisexual men who have sex with men, female sex workers, and people who use drugs to use and pay for HIV prevention commodities to support improved sustainable HIV prevention programming.
Financing & Costing, Research
Qualitative Inquiry into Perceptions of HIV Pre-exposure Prophylaxis among People who Inject Drugs Living with Hepatitis C in Seattle, WA, USA
This article from Harm Reduction Journal explores knowledge, attitudes, and perspectives of PrEP acceptability among people who use drugs in Seattle, Washington, USA.
Missed Opportunities for Healthcare Providers to Discuss HIV Preexposure Prophylaxis with People who Inject Drugs
This article from the International Journal of Drug Policy identifies missed opportunities for healthcare providers to discuss PrEP with people who inject drugs.
Acceptability of Injectable Pre-exposure Prophylaxis among People who Inject Drugs in Three Urban U.S. Settings
This article from BMC Infectious Diseases examines acceptability of injectable PrEP amongst people who inject drugs in the US.
Consolidated Guidelines on HIV, Viral Hepatitis and STI Prevention, Diagnosis, Treatment and Care for Key Populations (2022)
Released in July 2022, the consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations outline a public health response for five key populations (men who have sex with men, trans and gender diverse people, sex workers, people who inject drugs and people in prisons and other closed settings).…
HIV Prevention Ambassador Training Package and Toolkit
The HIV Prevention Ambassador Training Package and Toolkit is designed for community-based organizations and other groups to train HIV Prevention Ambassadors with the goal of promoting the meaningful engagement of communities and potential and current PrEP users in the rollout of oral PrEP for HIV prevention.
Community/Advocacy, Demand creation/marketing